出典(authority):フリー百科事典『ウィキペディア(Wikipedia)』「2013/06/20 09:53:40」(JST)
Pilocytic astrocytoma | |
---|---|
Classification and external resources | |
Micrograph of a pilocytic astrocytoma, showing characteristic bipolar cells with long pilocytic (hair-like) processes. Smear preparation. H&E stain. |
|
ICD-10 | C71 |
ICD-9 | 191 |
ICD-O: | M9421/1 |
eMedicine | radio/367 |
MeSH | D001254 |
Pilocytic astrocytoma or juvenile pilocytic astrocytoma or cystic cerebellar astrocytoma (and its variant juvenile pilomyxoid astrocytoma) is a neoplasm of the brain that occurs more often in children and young adults (in the first 20 years of life). They usually arise in the cerebellum, near the brainstem, hypothalamic region, or the optic chiasm, but they may occur in any area where astrocytes are present, including the cerebral hemispheres and the spinal cord. These tumors are usually slow growing. The neoplasms are associated with the formation of a single (or multiple) cyst(s), and can become very large.
The pilocytic astrocytoma is, in general, considered a benign tumor. It is often cystic, and, if solid, it tends to be well-circumscribed. It is characteristically a contrast-enhancing tumor by current imaging investigations (e.g., CT scan, MRI)
Juvenile pilocytic astrocytoma is associated with neurofibromatosis type 1 (NF1), and optic gliomas are among the most frequently encountered tumors in patients with this disorder.
It is classified as Grade 1 Astrocytoma.[1]
Contents
|
Children affected by pilocytic astrocytoma can present with different symptoms that might include failure to thrive (lack of appropriate weight gain), headache, nausea, vomiting, irritability, difficulty to coordinate movements and visual complaints (including nystagmus). The complaints may vary depending on the location and size of the neoplasm. The most common symptoms are associated with increased intracranial pressure due to the size of the neoplasm.
According to a Dutch source juvenile pilocytic astrocytoma occurs at a rate of 2 in 100,000 people. Most affected are children ages 5–14 years.[2]
Tumors of the optic pathway account for 3.6-6% of pediatric brain tumors, 60% of which are juvenile pilocytic astrocytomas. Astrocytomas account for 50% of pediatric primary central nervous system tumors. About 80-85% of cerebellar astrocytomas are juvenile pilocytic astrocytomas. Quoted from emedicine [3]
Recent genetic studies of pilocytic astrocytomas show that some sporadic cases have gain in chromosome 7q34 involving the BRAF locus (Bar et al, 2008).
Usually—depending on the interview of the patient and after a clinical exam which includes a neurological exam, and an ophthalmological exam—a CT scan and or MRI scan will be performed. A special dye may be injected into a vein before these scans to provide contrast and make tumors easier to identify. The neoplasm will be clearly visible.
If a tumor is found, it will be necessary for a neurosurgeon to perform a biopsy of it. This simply involves the removal of a small amount of tumorous tissue, which is then sent to a (neuro)pathologist for examination and staging.[4] The biopsy may take place before surgical removal of the tumor or the sample may be taken during surgery.
Macroscopically, an astrocytoma is a mass that looks well-circumscribed and has a large cyst. The neoplasm may also be solid.
Under the microscope, the tumor is seen to be composed of bipolar cells with long "hairlike" GFAP-positive processes, giving the designation "pilocytic" (that is, made up of cells that look like fibers when viewed under a microscope[5]). Some pilocytic astrocytomas may be more fibrillary and dense in composition. There is often presence of Rosenthal fibers,[6] eosinophilic granular bodies and microcysts. Myxoid foci and oligodendroglioma-like cells may also be present, though non-specific. Long-standing lesions may show hemosiderin-laden macrophages and calcifications.
Surgery is often the treatment of choice. Total resection is often possible; however, the location could prohibit access to the neoplasm and lead to incomplete or no resection at all. Removal of the tumor will generally allow functional survival for many years. The five-year survival has been reported to be over 90% with well-resected tumors. In particular for pilocytic astrocytomas (that are commonly indolent bodies that may permit normal neurologic function) surgeons may decide to monitor the neoplasm's evolution and postpone surgical intervention for some time. However, left unattended these tumors may eventually undergo neoplastic transformation.
Some articles mention ultrasonic aspiration as a minimal invasive technique for solid neoplasms.[citation needed]
Because of the age of people diagnosed with pilocytic astrocytoma, the treating medical team will often try to avoid radiotherapy and chemotherapy in order avoid damage to the developing brain. There is evidence in literature to suggest that the careful use of chemotherapy and/or radiation therapy may be useful as a complementary treatment in case of incompletely resection of the neoplasm.
Children with cerebellar pilocytic astrocytoma may experience side effects related to the tumor itself and related to the treatment. Strabismus.
Any person undergoing brain surgery may suffer from epileptic seizures.
Parents of children after surgery should be made aware of this fact and should be prepared to take adequate action in case of the seizure (see brain tumor)
Common side effects of chemotherapy includes nausea, vomiting and decreased blood counts (i.e. anemia).
Juvenile pilocytic astrocytomas that are initially characterized according to WHO grade I have been found to undergo malignant transformation following radiation treatment.[7]
Radiation therapy may cause swelling related to tissue inflammation.
The recommended course of action according to different literature sources is to monitor and reattempt a complete surgical removal. In cases of progressive/recurrent disease or when maximal surgical removal has been achieved, chemotherapy and/or radiation therapy will be considered by the medical team.
After total resection the 10-year survival rate is 90%. After incomplete resection, the 10-year survival rate is as high as 45%. Morbidity is determined by the location (and accessibility) of the tumor and with the associated complications for a tumor resection.
Histopathology of pilocytic astrocytoma (grade I WHO). H&E stain. Original magnification 200x.
Histopathology of Rosenthal-fibres. H&E staining showing these elongated eosinophilic structures in a case of pilocytic astrocytoma. Magnification 400x
|
全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.
リンク元 | 「脳腫瘍」「星状細胞腫」「神経膠腫」「毛様細胞性星細胞腫」「subependymal giant cell astrocytoma」 |
腫瘍別発生頻度 | 小児 | 成人 | |
神経膠腫 | 33% | 星状細胞腫 | 髄膜腫 |
髄膜腫 | 22% | 髄芽腫 | 膠芽腫 |
下垂体腺腫 | 15% | 頭蓋咽頭腫 | 下垂体腺腫 |
神経鞘腫 | 9% | 胚細胞腫 | 神経鞘腫 |
頭蓋咽頭腫 | 5% | 上衣腫 | 転移性脳腫瘍 |
部位 | 種類 | 小児 | 成人 |
頭蓋骨 | 頭蓋骨腫瘍 | ○ | ○ |
大脳半球 | 神経膠腫 | ○ | |
髄膜腫 | ○ | ||
松果体 | 胚細胞腫 | ○ | |
小脳半球 | 星細胞腫 | ○ | |
血管芽腫 | ○ | ||
小脳虫部 | 髄芽腫 | ○ | |
第四脳室 | 上衣腫 | ○ | |
鞍上部・ 視交叉部・ 下垂体部 |
頭蓋咽頭腫 | ○ | |
視神経膠腫 | ○ | ||
胚細胞腫 | ○ | ||
下垂体腺腫 | ○ | ||
髄膜腫 | ○ | ||
小脳橋角部 | 聴神経鞘腫 | ○ | |
脳幹部 | 神経膠腫 | ○ | ○ |
後発年齢 | 好発部位 | |
小脳星細胞腫 | 5~10歳 | 小脳半球 |
髄芽腫 | 5~10歳(男児に多い) | 小脳虫部から発生 |
頭蓋咽頭腫 | 10~15歳 | トルコ鞍上部 |
上衣腫 | 10~15,30~40歳 | 第四脳室、側脳室 |
髄芽腫 | 10~30歳 | 松果体部、トルコ鞍上部 |
脳幹部膠腫 | ~15歳 | 橋 |
視神経膠腫 | ~15歳 | 視神経視交叉 |
.